Firas Bassissi

Firas Bassissi

LinkedIn - - / United States
Others
AD Scientific Index ID: 5667118
-
person_outline Firas Bassissi's MOST POPULAR ARTICLES
1-) TRO40303, a new cardioprotective compound, inhibits mitochondrial permeability transitionS Schaller, S Paradis, GA Ngoh, R Assaly, B Buisson, C Drouot, ...Journal of Pharmacology and Experimental Therapeutics 333 (3), 696-706, 20101422010
2-) GNS561, a clinical-stage PPT1 inhibitor, is efficient against hepatocellular carcinoma via modulation of lysosomal functionsS Brun, E Bestion, E Raymond, F Bassissi, ZM Jilkova, S Mezouar, ...Autophagy 18 (3), 678-694, 2022412022
3-) Contribution of lymphatic transport to the systemic exposure of orally administered moxidectin in conscious lymph duct-cannulated dogsA Lespine, G Chanoit, A Bousquet-Melou, E Lallemand, FM Bassissi, ...European journal of pharmaceutical sciences 27 (1), 37-43, 2006402006
4-) Breed differences in the pharmacokinetics of ivermectin administered subcutaneously to Holstein and Belgian Blue calvesJ Vercruysse, P Deprez, D Everaert, F Bassissi, M AlvinerieVeterinary Parasitology 152 (1-2), 136-140, 2008372008
5-) Assessment of a liposomal formulation of ivermectin in rabbit after a single subcutaneous administrationF Bassissi, A Lespine, M AlvinerieParasitology Research 98, 244-249, 2006272006